Yes, the company does actually want to keep dilution to a minimum. The need of a CR is unknown, it is speculation. Speculation does have a place.
A fair bit of speculation is used in some peoples evaluation of the SP, yet I don't see people scream to keep it at facts when those evaluations are talking up the company.
In the end we are all pretty darn sure that the company's real value is going up.
- Forums
- ASX - By Stock
- VYS
- commissioning
commissioning, page-36
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VYS (ASX) to my watchlist
(20min delay)
|
|||||
Last
47.5¢ |
Change
-0.005(1.04%) |
Mkt cap ! $243.1M |
Open | High | Low | Value | Volume |
47.5¢ | 47.5¢ | 46.5¢ | $226.7K | 481.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 96839 | 47.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.5¢ | 5073 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 96839 | 0.470 |
4 | 55684 | 0.465 |
5 | 73622 | 0.460 |
1 | 1120 | 0.455 |
4 | 18326 | 0.450 |
Price($) | Vol. | No. |
---|---|---|
0.475 | 5073 | 1 |
0.480 | 212126 | 8 |
0.485 | 9933 | 5 |
0.490 | 18063 | 2 |
0.495 | 104000 | 2 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
VYS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online